VG Life Sciences, Inc. Announces Management Changes
SANTA BARBARA, Calif., July 18, 2013 /PRNewswire/ -- VG Life Sciences, (OTC Pink: VGLS) a biotechnology company, announces alterations in its corporate management and management structure.
Interim CEO & President
John Tynan has been named Interim CEO & President of VG Life Sciences, inc, effective immediately. Mr. Tynan started TynanGroup, Inc. in 1991 and grew it to successful company as a leader in real estate development services across the country, overseeing more than $4 billion of construction. TynanGroup was on INC Magazine's list of the fasting growing companies and today includes a host of sister companies including MedBridge Development Company, LLC and Anchor Point IT Solutions. Prior to starting TynanGroup, he was Vice President for Hyatt Development Corporation where he oversaw $1.5 Billion project expenditures and over 9,000 people. Mr. Tynan has a BS in Civil Engineering from the University of Illinois and a MBA in finance from DePaul University. "My focus is on achieving specific goals to increase shareholders' value and support our exceptional research team," said Tynan. Haig Keledjian will stay on as Chairman of the Board and VP of Intellectual Property and Product Development.
For more information on the goals and direction of the company as well as the new management structure of VG Life Sciences, please see the July 18th, 2013 investor letter, which can be downloaded from the company site and viewed here.
About VG Life Sciences Inc.
Santa Barbara, California-based VG Life Sciences Inc., formerly known as Viral Genetics, is a biotechnology company focused on discovering and developing drug therapies for cancer, infectious diseases, and autoimmune disorders. VGLS controls over 50 US and international patents and pending patents protecting its exclusive biotech platform technologies. For more information, visit www.vglifesciences.com.
CONTACT:
Alexandria Sumner, Corporate Communications
VG Life Sciences, Inc.
Phone: (805) 679-6763
Email: Alex@vglifesciences.com
SOURCE VG Life Sciences, Inc.
RELATED LINKS
http://www.vglifesciences.com
More by this Source
VG Life Sciences, Inc. Closes on $2,235,000 from Private Fund
Oct 02, 2013, 06:00 ET
VG Energy Chief Scientist Awarded $200,000 AgriLife Grant to Study Lipid Secretion
Aug 08, 2013, 19:50 ET
VG Life Sciences, Inc. Reports on Scientific Advancements: Completion of Third Cohort of Phase I Clinical Trial; Grant from the American Heart Association; UniQuest Reports on LipidMax
Jul 25, 2013, 06:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.